| Selsun Shampoo 2.5% w/v PA23180/013/001 |
Selenium disulfide |
Opella Healthcare France SAS T/A Sanofi |
Not marketed |
| Sevelamer carbonate Winthrop 0.8 g powder for oral suspension EU/1/14/952/005-006 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer carbonate Winthrop 2.4 g powder for oral suspension EU/1/14/952/002-003 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer carbonate Winthrop 800 mg film-coated tablets EU/1/14/952/001 |
Sevelamer carbonate, Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer Hydrochloride Zentiva EU/1/14/953/001 |
Sevelamer hydrochloride |
Sanofi B.V. |
— |
| Solian 100mg Tablets PA0540/158/002 |
Amisulpride |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Solian 200mg Tablets PA0540/158/003 |
Amisulpride |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Solian 400mg Film-coated Tablets PA0540/158/004 |
Amisulpride |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Solian 50mg Tablets PA0540/158/001 |
Amisulpride |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| STAMARIL, powder and solvent for suspension for injection in pre-filled syringe. Yellow fever vaccine (Live) PA23458/006/001 |
Yellow fever virus 17 d-204 strain |
Sanofi Winthrop Industrie |
Marketed |
| Stilnoct 10 mg Film-coated Tablets PA0540/160/002 |
Zolpidem tartrate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Stilnoct 5 mg Film Coated Tablets PA0540/160/001 |
Zolpidem tartrate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Not marketed |
| Suliqua 100 units/ml + 33 micrograms/ml solution for injection in pre-filled pen EU/1/16/1157/003-004 |
Lixisenatide, Insulin glargine |
Sanofi-Aventis Groupe |
— |
| Suliqua 100 units/ml + 50 micrograms/ml solution for injection in pre-filled pen EU/1/16/1157/001-002 |
Insulin glargine, Lixisenatide |
Sanofi-Aventis Groupe |
— |
| Supemtek Tetra solution for injection in pre-filled syringe EU/1/20/1484/001-006 |
A/(H1N1)-LIKE VIRUS ANTIGEN |
Sanofi Winthrop Industrie |
— |
| Suvezen 10 mg/10 mg film-coated tablets PA0540/193/001 |
Rosuvastatin, Ezetimibe |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Suvezen 20 mg/10 mg film-coated tablets PA0540/193/002 |
Rosuvastatin, Ezetimibe |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Suvezen 40 mg/10 mg film-coated tablets PA0540/193/003 |
Rosuvastatin, Ezetimibe |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Targocid 200mg Powder and Solvent for Solution for Injection/infusion or oral solution PA0540/021/001 |
Teicoplanin |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Targocid 400mg Powder and Solvent for Solution for Injection/infusion or oral solution PA0540/021/002 |
Teicoplanin |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Taxotere 20 mg/0.5 ml Concentrate and solvent for solution for infusion EU/1/95/002/001 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 20 mg/1 ml Concentrate and solvent for solution for infusion EU/1/95/002/003 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 80 mg/2 ml Concentrate and solvent for solution for infusion EU/1/95/002/002 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Taxotere 80 mg/4 ml Concentrate and solvent for solution for infusion EU/1/95/002/004 |
Docetaxel trihydrate |
Sanofi Winthrop Industrie |
— |
| Telfast 120 mg film-coated tablets PA23180/003/002 |
Fexofenadine hydrochloride |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Telfast 180 mg film-coated tablets PA23180/003/003 |
Fexofenadine hydrochloride |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Telfast 30 mg film-coated tablets PA23180/003/001 |
Fexofenadine hydrochloride |
Opella Healthcare France SAS T/A Sanofi |
Not marketed |
| Telfast Allergy 120 mg film-coated tablets PA23180/014/001 |
Fexofenadine hydrochloride |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Tetravac, suspension for injection in prefilled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine, (adsorbed). PA23458/007/001 |
Adsorbed purified pertussis toxoid, Adsorbed purified filamentous haemagglutinin, Purified tetanus toxoid, Purified diphtheria toxoid ph. eur., Inactivated type 1 poliovirus |
Sanofi Winthrop Industrie |
Marketed |
| Thymoglobuline 25 mg powder for solution for infusion PA0611/003/001 |
Rabbit anti-human thymocyte immunoglobulin |
Sanofi B.V. |
Marketed |
| Thyrogen 0.9 mg Powder for solution for injection EU/1/99/122/001 |
Thyrotropin alfa |
Sanofi Winthrop Industrie |
— |
| Thyrogen 0.9 mg Powder for solution for injection EU/1/99/122/002 |
Thyrotropin alfa |
Sanofi Winthrop Industrie |
— |
| Toujeo (previously Optisulin) 300 units/ml SoloStar solution for injection in a pre-filled pen EU/1/00/133/033-035 |
Insulin glargine |
Sanofi-Aventis Deutschland GmbH |
— |
| Triapin 2.5mg/2.5mg prolonged release tablet PA0540/082/001 |
Felodipine, Ramipril |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Triapin 5mg/5mg prolonged release tablet PA0540/082/002 |
Felodipine, Ramipril |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Triaxis, suspension for injection in a pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content) PA23458/008/001 |
Diphtheria toxoid, Tetanus toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin (prn) |
Sanofi Winthrop Industrie |
Not marketed |
| TRITACE 1.25 mg Tablets PA0540/084/005 |
Ramipril |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Not marketed |
| Tritace 10 mg Tablets PA0540/084/008 |
Ramipril |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Tritace 2.5 mg Tablets PA0540/084/006 |
Ramipril |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Tritace 5 mg Tablets PA0540/084/007 |
Ramipril |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Truvelog Mix 30 EU/1/22/1639/001-005 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Typhim Vi Solution for Injection Typhoid Polysaccharide Vaccine PA23458/009/001 |
Salmonella typhi, vi antigen |
Sanofi Winthrop Industrie |
Marketed |
| Vaxigrip suspension for injection in pre-filled syringe.Trivalent influenza vaccine (split virion, inactivated). PA23458/002/001 |
Influenza Inactivated Split Virus Strain A (H1N1), Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B |
Sanofi Winthrop Industrie |
Marketed |
| Verorab, powder and solvent for suspension for injection. Rabies vaccine, inactivated. PA23458/011/001 |
Rabies virus (inactivated) strain wistar (PM/WI 38-1503-3M) |
Sanofi Winthrop Industrie |
Marketed |
| WAYRILZ 400 mg film-coated tablets EU/1/25/1974/001-003 |
Rilzabrutinib |
Sanofi B.V. |
— |
| Xatral 10mg Prolonged Release Tablets PA0540/162/003 |
Alfuzosin hydrochloride |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Xenpozyme 20 mg powder for concentrate for solution for infusion EU/1/22/1659/001-004 |
Olipudase Alfa |
Sanofi B.V. |
— |
| ZALTRAP 25 mg/ml concentrate for solution for infusion EU/1/12/814/001-003 |
Aflibercept |
Sanofi Winthrop Industrie |
— |